| Year |
Citation |
Score |
| 2021 |
Gupta S, Sukov WR, Vanderbilt CM, Shen W, Herrera-Hernandez L, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE, Cheville JC. A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma. Urologic Oncology. PMID 34092479 DOI: 10.1016/j.urolonc.2021.04.042 |
0.301 |
|
| 2021 |
Takeuchi M, McDonald JS, Takahashi N, Frank I, Thompson RH, King BF, Kawashima A. Cancer Prevalence and Risk Stratification in Adults Presenting With Hematuria: A Population-Based Cohort Study. Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 5: 308-319. PMID 33997630 DOI: 10.1016/j.mayocpiqo.2020.12.001 |
0.432 |
|
| 2021 |
Sharma V, Miest TS, Juvet TS, Toussi A, Packiam V, Chamie K, Matin SF, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Potretzke AM. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated meta-Analysis. The Journal of Urology. 101097JU000000000000. PMID 33908802 DOI: 10.1097/JU.0000000000001834 |
0.343 |
|
| 2021 |
Miest TS, Sharma V, Karnes RJ, Boorjian SA, Thompson RH, Frank I, Tollefson MK. Incidence and predictors of occult preoperative deep vein thrombosis at radical cystectomy for urothelial carcinoma. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. PMID 33591896 DOI: 10.5489/cuaj.6852 |
0.327 |
|
| 2021 |
Gupta S, Jimenez RE, Herrera-Hernandez L, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Cheville JC. Renal Neoplasia in Tuberous Sclerosis: A Study of 41 Patients. Mayo Clinic Proceedings. PMID 33526281 DOI: 10.1016/j.mayocp.2020.11.004 |
0.323 |
|
| 2021 |
El Khoury LY, Fu S, Hlady RA, Wagner RT, Wang L, Eckel-Passow JE, Castle EP, Stanton ML, Thompson RH, Parker AS, Ho TH, Robertson KD. Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer. Clinical Epigenetics. 13: 12. PMID 33461589 DOI: 10.1186/s13148-020-00998-z |
0.368 |
|
| 2020 |
Bearrick EN, Packiam V, Bhindi B, Lohse CM, Cheville JC, Mason RJ, Tollefson M, Harrington S, Dong H, Parker AS, Boorjian SA, Thompson RH, Leibovich BC. Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma. Urologic Oncology. PMID 33309297 DOI: 10.1016/j.urolonc.2020.08.028 |
0.366 |
|
| 2020 |
Avulova S, Cheville JC, Lohse CM, Gupta S, Potretzke TA, Tsivian M, Thompson RH, Boorjian SA, Leibovich BC, Potretzke AM. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. European Urology. PMID 33172723 DOI: 10.1016/j.eururo.2020.10.007 |
0.359 |
|
| 2020 |
Miest TS, Sharma V, Boeri L, Tollefson MK, Thompson RH, Boorjian SA, Frank I, Karnes RJ. Does ureteral stent drainage prior to cystectomy increase the risk of subsequent upper tract urothelial carcinoma and ureteral complications? Urology. PMID 32763318 DOI: 10.1016/j.urology.2020.07.034 |
0.357 |
|
| 2020 |
Gupta S, Vanderbilt CM, Leibovich BC, Herrera-Hernandez L, Raghunathan A, Sukov WR, Voss JS, Barr Fritcher EG, Reed KA, Lohse CM, Reuter VE, Jimenez RE, Thompson RH, Cheville JC. Secondary Renal Neoplasia Following Chemotherapy or Radiation in Pediatric Patients. Human Pathology. PMID 32681944 DOI: 10.1016/J.Humpath.2020.07.014 |
0.388 |
|
| 2020 |
Yang DY, Potretzke TA, Miest TS, Bhindi B, Lohse CM, Cheville JC, King BF, Boorjian SA, Leibovich BC, Thompson RH, Potretzke AM. Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomy. International Journal of Urology : Official Journal of the Japanese Urological Association. PMID 32424856 DOI: 10.1111/iju.14261 |
0.422 |
|
| 2020 |
Leibovich BC, Lohse CM, Cheville JC, Potretzke TA, Tsivian M, Shah PH, Boorjian SA, Thompson RH, Lyon TD. Renal Cell Carcinoma with Inferior Vena Cava Extension: Can Classification Be Optimized to Predict Perioperative Outcomes? Kidney Cancer. 4: 111-115. DOI: 10.3233/kca-190070 |
0.375 |
|
| 2020 |
Sharma* V, Miest T, Boeri L, Thapa P, Tollefson MK, Thompson RH, Boorjian SA, Frank I, Karnes RJ. MP82-20 URETERAL STENT PLACEMENT VS NEPHROSTOMY TUBE PLACEMENT PRIOR TO RADICAL CYSTECTOMY DOES NOT INCREASE POST-CYSTECTOMY UPPER TRACT UROTHELIAL CARCINOMA The Journal of Urology. 203: e1254. DOI: 10.1097/ju.0000000000000974.020 |
0.309 |
|
| 2020 |
Avulova* S, Cheville JC, Lohse C, Tsivian M, Thompson RH, Leibovich BC, Potretzke AM. MP50-15 CHROMOPHOBE RENAL CELL CARCINOMA – EVIDENCE FOR A NEW GRADING SYSTEM Journal of Urology. 203. DOI: 10.1097/JU.0000000000000912.015 |
0.427 |
|
| 2019 |
Packiam VT, Tyson Ii MD, Tsivian M, Lohse CM, Boorjian SA, Cheville JC, Costello BA, Leibovich BC, Thompson RH. The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomy. Urologic Oncology. PMID 31761613 DOI: 10.1016/j.urolonc.2019.10.017 |
0.341 |
|
| 2019 |
Joseph JP, Potretzke TA, Packiam V, Sharma V, Toussi A, Miest TS, Juvet T, Boorjian SA, Thompson RH, Welle CL, Atwell TD, Leibovich BC, Tollefson MK, Potretzke AM. Percutaneous Image-Guided Core Needle Biopsy for Upper Tract Urothelial Carcinoma. Urology. PMID 31655078 DOI: 10.1016/j.urology.2019.10.005 |
0.304 |
|
| 2019 |
Golijanin B, Pereira J, Mueller-Leonhard C, Golijanin D, Amin A, Mega A, Boorjian SA, Thompson RH, Leibovich BC, Gershman B. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013. Urologic Oncology. PMID 31570248 DOI: 10.1016/j.urolonc.2019.08.003 |
0.364 |
|
| 2019 |
Lyon TD, Thompson RH, Shah PH, Lohse CM, Boorjian SA, Costello BA, Cheville JC, Leibovich BC. Complete Surgical Metastasectomy for Renal Cell Carcinoma in the Post-cytokine Era. The Journal of Urology. 101097JU000000000000. PMID 31393812 DOI: 10.1097/JU.0000000000000488 |
0.386 |
|
| 2019 |
Westerman ME, Cheville JC, Lohse CM, Sharma V, Boorjian SA, Leibovich BC, Thompson RH. Long Term Outcomes of Patients with Low Grade Cystic Renal Epithelial Neoplasms. Urology. PMID 31356826 DOI: 10.1016/j.urology.2019.07.017 |
0.349 |
|
| 2019 |
Gupta S, Swanson AA, Chen YB, Lopez T, Milosevic D, Kipp BR, Leibovich BC, Thompson RH, Herrera-Hernandez L, Cheville JC, Jimenez RE. Incidence of Succinate Dehydrogenase and Fumarate Hydratase-Deficient Renal Cell Carcinoma Based on Immunohistochemical Screening with SDHA/SDHB and FH/2SC. Human Pathology. PMID 31299266 DOI: 10.1016/J.Humpath.2019.07.004 |
0.346 |
|
| 2019 |
Boswell TC, Sharma V, Westerman ME, Dean PG, Chow GK, Thompson RH, Leibovich BC, Boorjian SA. Frequency and Predictors of Renal Transplantation Among Patients Rendered Surgically Anephric for Sporadic Renal Cancer. Urology. PMID 30648561 DOI: 10.1016/j.urology.2018.12.037 |
0.312 |
|
| 2019 |
Atwell TD, Schultz GG, Leibovich BC, Schmit GD, Boorjian SA, Kurup AN, Thompson RH, Yost KJ. Patient-Reported Outcomes After Percutaneous Renal Ablation: Initial Experience. Ajr. American Journal of Roentgenology. 212: 672-676. PMID 30620680 DOI: 10.2214/AJR.17.19463 |
0.363 |
|
| 2019 |
Shah* P, Leibovich B, Van Houten H, Lyon T, Yao X, Shah P, Yao X, Knoedler M, Sangaralingham L, Kattah A, Thompson RH, Shah N, Boorjian S. MP42-13 ASSOCIATION OF PARTIAL VERSUS RADICAL NEPHRECTOMY WITH SUBSEQUENT HYPERTENSION RISK FOLLOWING RENAL TUMOR RESECTION Journal of Urology. 201. DOI: 10.1097/01.JU.0000556216.81550.0b |
0.325 |
|
| 2019 |
Lyon* T, Thompson RH, Lohse C, Shah P, Boorjian S, Costello B, Cheville J, Leibovich B. MP25-06 COMPLETE METASTASECTOMY FOR RENAL CELL CARCINOMA IN THE CONTEMPORARY ERA Journal of Urology. 201. DOI: 10.1097/01.JU.0000555651.43215.9d |
0.455 |
|
| 2018 |
Salagierski M, Wojciechowska A, Zając K, Klatte T, Thompson RH, Cadeddu JA, Kaouk J, Autorino R, Ahrar K, Capitanio U. The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses. European Urology Oncology. 1: 395-402. PMID 31158078 DOI: 10.1016/j.euo.2018.08.029 |
0.36 |
|
| 2018 |
Bhindi B, Lohse CM, Schulte PJ, Mason RJ, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Predicting Renal Function Outcomes After Partial and Radical Nephrectomy. European Urology. PMID 30477983 DOI: 10.1016/J.Eururo.2018.11.021 |
0.331 |
|
| 2018 |
Rieken M, Boorjian SA, Kluth LA, Capitanio U, Briganti A, Thompson RH, Leibovich BC, Krabbe LM, Margulis V, Raman JD, Regelman M, Karakiewicz PI, Rouprêt M, Abufaraj M, Foerster B, et al. Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma. World Journal of Urology. PMID 30406477 DOI: 10.1007/s00345-018-2555-5 |
0.362 |
|
| 2018 |
Gershman B, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma. European Urology. PMID 30262341 DOI: 10.1016/j.eururo.2018.08.028 |
0.383 |
|
| 2018 |
Shah PH, Lyon TD, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA, Thompson RH. Prognostic Evaluation of Perinephric Fat, Renal Sinus Fat, and Renal Vein Invasion for Patients with Pathologic Stage T3a Clear Cell Renal Cell Carcinoma. Bju International. PMID 30113768 DOI: 10.1111/bju.14523 |
0.445 |
|
| 2018 |
Haddad MM, Schmit GD, Kurup AN, Schmitz JJ, Boorjian SA, Geske J, Thompson RH, Callstrom MR, Atwell TD. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes. Journal of Vascular and Interventional Radiology : Jvir. PMID 29887184 DOI: 10.1016/j.jvir.2018.02.029 |
0.435 |
|
| 2018 |
Mason RJ, Atwell T, Lohse C, Bhindi B, Schmit G, Schmitz J, Leibovich BC, Boorjian SA, Thompson RH. Synchronous nephron sparing approaches for bilateral renal masses: Perioperative and renal functional outcomes. Bju International. PMID 29603885 DOI: 10.1111/bju.14221 |
0.358 |
|
| 2018 |
Schmit CH, Callstrom MR, Boorjian SA, Johnson MP, Atwell TD, Kurup AN, Schultz GR, Thompson RH, Schmit GD. A Comparison of Bleeding Complications in Patients Undergoing Percutaneous Renal Cryoablation Using Cryoprobes with and without Heat-Based Track Ablation. Journal of Vascular and Interventional Radiology : Jvir. PMID 29506903 DOI: 10.1016/j.jvir.2017.11.009 |
0.307 |
|
| 2018 |
Hutchinson R, Rew C, Chen G, Woldu S, Krabbe LM, Meissner M, Sheth K, Singla N, Shakir N, Master VA, Karam JA, Matin SF, Borregales LD, Wood C, Masterson T, ... Thompson RH, et al. The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma with Venous Tumor Thrombus. Urology. PMID 29499258 DOI: 10.1016/j.urology.2018.02.019 |
0.408 |
|
| 2018 |
Bhindi B, Wallis CJD, Boorjian SA, Thompson RH, Farrell A, Kim SP, Karam JA, Capitanio U, Golijanin D, Leibovich BC, Gershman B. The Role of Lymph Node Dissection in the Management of Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Bju International. PMID 29319926 DOI: 10.1111/bju.14127 |
0.35 |
|
| 2018 |
Shah P, Lyon T, Lohse C, Cheville J, Leibovich B, Boorjian S, Thompson RH. PD16-12 PROGNOSTIC EVALUATION OF PERINEPHRIC FAT, RENAL SINUS FAT, AND RENAL VEIN INVASION FOR PATIENTS WITH PATHOLOGIC STAGE T3A RENAL CELL CARCINOMA Journal of Urology. 199. DOI: 10.1016/J.JURO.2018.02.824 |
0.406 |
|
| 2018 |
Bhindi B, Lohse C, Cheville J, Mason R, Tollefson M, Harrington S, Dong H, Parker A, Boorjian S, Thompson RH, Leibovich B. PD57-02 CREATION OF A TISSUE EXPRESSION BIOMARKER-AUGMENTED PROGNOSTIC MODEL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA Journal of Urology. 199. DOI: 10.1016/J.JURO.2018.02.2646 |
0.337 |
|
| 2018 |
Bhindi B, Cheville J, Lohse C, Mason R, Harrington S, Dong H, Boorjian S, Thompson RH, Leibovich B. MP66-12 BIM EXPRESSION IN PERITUMORAL LYMPHOCYTES IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN PATIENTS WITH METASTATIC CLEAR CELL RENAL CELL CARCINOMA Journal of Urology. 199. DOI: 10.1016/J.JURO.2018.02.1884 |
0.408 |
|
| 2018 |
Yang D, Potretzke T, Lohse C, Cheville J, King B, Leibovich B, Thompson RH, Potretzke A. MP66-03 DISTRIBUTION OF M0 RENAL CELL CARCINOMA METASTASES STRATIFIED BY PATHOLOGIC NODAL STATUS Journal of Urology. 199. DOI: 10.1016/J.JURO.2018.02.1875 |
0.382 |
|
| 2018 |
Gershman B, Thompson RH, Boorjian S, Lohse C, Costello B, Cheville J, Leibovich B. MP48-14 RADICAL VERSUS PARTIAL NEPHRECTOMY FOR CT1 RENAL CELL CARCINOMA: A PROPENSITY-SCORE BASED ANALYSIS Journal of Urology. 199. DOI: 10.1016/J.JURO.2018.02.1513 |
0.376 |
|
| 2018 |
Bhindi B, Habermann E, Mason R, Costello B, Pagliaro L, Thompson RH, Leibovich B, Boorjian S. PD24-03 SURVIVAL FOLLOWING UPFRONT CYTOREDUCTIVE NEPHRECTOMY VERSUS TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1196 |
0.34 |
|
| 2017 |
Gershman B, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma: A Propensity Score-based Analysis. European Urology. PMID 29132713 DOI: 10.1016/j.eururo.2017.10.020 |
0.342 |
|
| 2017 |
Atwell TD, Kurup AN, Boorjian SA, Schmitz JJ, Thompson RH, Leibovich BC, Schmit GD. Percutaneous Cryoablation of Renal Cell Carcinoma with Sinus Vein Involvement Based on Preprocedural Imaging. Journal of Vascular and Interventional Radiology : Jvir. PMID 29042169 DOI: 10.1016/j.jvir.2017.08.008 |
0.445 |
|
| 2017 |
Bhindi B, Mason RJ, Haddad MM, Boorjian SA, Leibovich BC, Atwell TD, Weisbrod AJ, Schmit GD, Thompson RH. Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis. European Urology. PMID 28967553 DOI: 10.1016/j.eururo.2017.09.009 |
0.303 |
|
| 2017 |
Mason RJ, Atwell TD, Lohse C, Bhindi B, Weisbrod A, Boorjian SA, Leibovich BC, Schmit GD, Thompson RH. Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass. Bju International. PMID 28548236 DOI: 10.1111/bju.13917 |
0.355 |
|
| 2017 |
Huang J, Atwell TD, Kurup AN, Boorjian SA, Thompson RH, Schmit GD. Percutaneous Cryoablation of the Horseshoe Kidney: An Initial Experience. Journal of Vascular and Interventional Radiology : Jvir. 28: 498-501. PMID 28343584 DOI: 10.1016/j.jvir.2016.10.026 |
0.378 |
|
| 2017 |
Gupta S, Johnson SH, Vasmatzis G, Porath B, Rustin JG, Rao P, Costello BA, Leibovich BC, Thompson RH, Cheville JC, Sukov WR. TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 28338654 DOI: 10.1038/Modpathol.2017.24 |
0.361 |
|
| 2017 |
Gershman B, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection. European Urology. PMID 28094055 DOI: 10.1016/j.eururo.2016.12.027 |
0.346 |
|
| 2016 |
Parker WP, Boorjian SA, Zaid HB, Cheville JC, Leibovich BC, Thompson RH. Surgical Management and Oncologic Outcomes of Recurrent Venous Tumor Thrombus after Prior Nephrectomy for Renal Cell Carcinoma. European Urology Focus. 2: 625-630. PMID 28723495 DOI: 10.1016/j.euf.2016.05.003 |
0.471 |
|
| 2016 |
Serie DJ, Joseph RW, Cheville JC, Ho TH, Parasramka M, Hilton T, Thompson RH, Leibovich BC, Parker AS, Eckel-Passow JE. Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness. European Urology. PMID 27899233 DOI: 10.1016/J.Eururo.2016.11.018 |
0.375 |
|
| 2016 |
Bailey GC, Boorjian SA, Ziegelmann MJ, Westerman ME, Lohse CM, Leibovich BC, Cheville JC, Thompson RH. Urinary collecting system invasion is associated with poor survival in clear cell renal cell carcinoma patients. Bju International. PMID 27696652 DOI: 10.1111/bju.13669 |
0.464 |
|
| 2016 |
Parker WP, Lohse CM, Zaid HB, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma. Urologic Oncology. PMID 27687543 DOI: 10.1016/j.urolonc.2016.08.013 |
0.334 |
|
| 2016 |
Gershman B, Thompson RH, Moreira DM, Boorjian SA, Tollefson MK, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis. European Urology. PMID 27671144 DOI: 10.1016/j.eururo.2016.09.019 |
0.35 |
|
| 2016 |
Joyce DD, Psutka SP, Groeschl RT, Thompson RH, Boorjian SA, Cheville JC, Stewart-Merrill SB, Lohse CM, Costello BA, Que FG, Leibovich BC. Complications and Outcomes Associated with Surgical Management of Renal Cell Carcinoma Involving the Liver: a Matched Cohort Study. Urology. PMID 27544035 DOI: 10.1016/j.urology.2016.08.015 |
0.438 |
|
| 2016 |
Psutka SP, Heidenreich M, Boorjian SA, Bailey GC, Cheville JC, Stewart-Merrill SB, Lohse CM, Atwell TD, Costello BA, Leibovich BC, Thompson RH. Renal fossa recurrence following nephrectomy for renal cell carcinoma: prognostic features and oncologic outcomes. Bju International. PMID 27489013 DOI: 10.1111/bju.13620 |
0.416 |
|
| 2016 |
Zaid HB, Parker WP, Safdar NS, Gershman B, Erwin PJ, Murad MH, Boorjian SA, Costello BA, Thompson RH, Leibovich BC. Outcomes following complete surgical metastasectomy for patients with metastatic renal cell carcinoma: a systematic review and meta-analysis. The Journal of Urology. PMID 27473875 DOI: 10.1016/j.juro.2016.07.079 |
0.414 |
|
| 2016 |
Psutka SP, Cheville JC, Costello BA, Stewart-Merrill SB, Lohse CM, Leibovich BC, Boorjian SA, Thompson RH. Concordance of Pathologic Features between Metastatic Sites and the Primary Tumor in Surgically Resected Metastatic Renal Cell Carcinoma. Urology. PMID 27453217 DOI: 10.1016/j.urology.2016.06.061 |
0.444 |
|
| 2016 |
Viers BR, Thompson RH, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA, Tollefson MK. Pre-treatment neutrophil-to-lymphocyte ratio predicts tumor pathology in newly diagnosed renal tumors. World Journal of Urology. PMID 27052014 DOI: 10.1007/s00345-016-1821-7 |
0.37 |
|
| 2016 |
Moreira DM, Gershman B, Lohse CM, Boorjian SA, Cheville JC, Leibovich BC, Thompson RH. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy. World Journal of Urology. PMID 26914818 DOI: 10.1007/s00345-016-1793-7 |
0.425 |
|
| 2016 |
Gershman B, Takahashi N, Moriera DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radiographic Size of Retroperitoneal Lymph Nodes Predicts Pathologic Nodal Involvement for Patients with Renal Cell Carcinoma: Development of a Risk Prediction Model. Bju International. PMID 26800148 DOI: 10.1111/bju.13424 |
0.317 |
|
| 2016 |
Gershman B, Moreira D, Thompson RH, Boorjian S, Lohse C, Costello B, Cheville J, Leibovich B. MP64-01 RETROPERITONEAL LYMPH NODE DISSECTION IS NOT ASSOCIATED WITH SURVIVAL OUTCOMES AMONG PATIENTS UNDERGOING RADICAL NEPHRECTOMY FOR NON-METASTATIC RENAL CELL CARCINOMA: A PROPENSITY-SCORE BASED ANALYSIS Journal of Urology. 195. DOI: 10.1016/J.JURO.2016.02.951 |
0.355 |
|
| 2016 |
Gershman B, Moreira D, Thompson RH, Boorjian S, Lohse C, Costello B, Cheville J, Leibovich B. MP03-11 RETROPERITONEAL LYMPH NODE DISSECTION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL AMONG PATIENTS UNDERGOING CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: A PROPENSITY-SCORE BASED ANALYSIS Journal of Urology. 195. DOI: 10.1016/J.JURO.2016.02.1904 |
0.348 |
|
| 2016 |
Gershman B, Takahashi N, Moreira D, Thompson RH, Boorjian S, Lohse C, Costello B, Cheville J, Leibovich B. MP03-05 RADIOGRAPHIC SIZE OF RETROPERITONEAL LYMPH NODES PREDICTS PATHOLOGIC NODAL INVOLVEMENT FOR PATIENTS UNDERGOING RADICAL NEPHRECTOMY FOR RENAL CELL CARCINOMA: DEVELOPMENT OF A RISK PREDICTION MODEL Journal of Urology. 195. DOI: 10.1016/J.JURO.2016.02.1898 |
0.324 |
|
| 2015 |
Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, Peto M, Al Mamun AA, Shinbrot E, Sethi A, Brooks S, ... ... Thompson RH, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The New England Journal of Medicine. PMID 26536169 DOI: 10.1056/Nejmoa1505917 |
0.446 |
|
| 2015 |
Stewart-Merrill SB, Thompson RH, Boorjian SA, Psutka SP, Lohse CM, Cheville JC, Leibovich BC, Frank I. Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26351352 DOI: 10.1200/JCO.2015.61.8009 |
0.412 |
|
| 2015 |
Gupta S, Thompson RH, Boorjian SA, Thapa P, Hernandez LP, Jimenez RE, Costello BA, Frank I, Cheville JC. High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma. Pathology. 47: 533-42. PMID 26308137 DOI: 10.1097/Pat.0000000000000301 |
0.382 |
|
| 2015 |
Psutka SP, Boorjian SA, Moynagh MR, Schmit GD, Costello BA, Thompson RH, Stewart-Merrill SB, Lohse CM, Cheville JC, Leibovich BC, Tollefson MK. Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer. The Journal of Urology. PMID 26292038 DOI: 10.1016/j.juro.2015.08.072 |
0.307 |
|
| 2015 |
Russell CM, Lue K, Fisher J, Kassouf W, Schwaab T, Sexton WJ, Tanguay S, Psutka SP, Thompson RH, Leibovich BC, Hanzly MI, Spiess PE, Boorjian SA. Oncologic control associated with surgical resection of isolated retroperitoneal lymph node recurrence from renal cell carcinoma. Bju International. PMID 26118331 DOI: 10.1111/bju.13212 |
0.38 |
|
| 2015 |
Tabayoyong W, Abouassaly R, Kiechle JE, Cherullo EE, Meropol NJ, Shah ND, Dong S, Thompson RH, Smaldone MC, Zhu H, Ialacci S, Kim SP. Variation in Surgical Margins Status by Surgical Approach Among Patients Undergoing Partial Nephrectomy for Small Renal Masses. The Journal of Urology. PMID 26094808 DOI: 10.1016/j.juro.2015.06.076 |
0.391 |
|
| 2015 |
Haddad AQ, Leibovich BC, Abel EJ, Luo JH, Krabbe LM, Thompson RH, Heckman JE, Merrill MM, Gayed BA, Sagalowsky AI, Boorjian SA, Wood CG, Margulis V. Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus. Urologic Oncology. PMID 26004163 DOI: 10.1016/j.urolonc.2015.04.010 |
0.408 |
|
| 2015 |
Klatte T, Ficarra V, Gratzke C, Kaouk J, Kutikov A, Macchi V, Mottrie A, Porpiglia F, Porter J, Rogers CG, Russo P, Thompson RH, Uzzo RG, Wood CG, Gill IS. A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy. European Urology. PMID 25911061 DOI: 10.1016/j.eururo.2015.04.010 |
0.302 |
|
| 2015 |
Atwell TD, Vlaminck JJ, Boorjian SA, Kurup AN, Callstrom MR, Weisbrod AJ, Lohse CM, Hartman WR, Stockland AH, Leibovich BC, Schmit GD, Thompson RH. Percutaneous cryoablation of stage t1b renal cell carcinoma: technique considerations, safety, and local tumor control. Journal of Vascular and Interventional Radiology : Jvir. 26: 792-9. PMID 25824313 DOI: 10.1016/j.jvir.2015.02.010 |
0.367 |
|
| 2015 |
Kaushik D, Frank I, Boorjian SA, Cheville JC, Eisenberg MS, Thapa P, Tarrell RF, Thompson RH. Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder. International Journal of Urology : Official Journal of the Japanese Urological Association. 22: 549-54. PMID 25761779 DOI: 10.1111/iju.12729 |
0.356 |
|
| 2015 |
Volpe A, Blute ML, Ficarra V, Gill IS, Kutikov A, Porpiglia F, Rogers C, Touijer KA, Van Poppel H, Thompson RH. Renal Ischemia and Function After Partial Nephrectomy: A Collaborative Review of the Literature. European Urology. 68: 61-74. PMID 25703575 DOI: 10.1016/j.eururo.2015.01.025 |
0.339 |
|
| 2015 |
Zhang BY, Cheville JC, Thompson RH, Lohse CM, Boorjian SA, Leibovich BC, Costello BA. Impact of Rhabdoid Differentiation on Prognosis for Patients with Grade 4 Renal Cell Carcinoma. European Urology. 68: 5-7. PMID 25638439 DOI: 10.1016/j.eururo.2015.01.002 |
0.369 |
|
| 2015 |
Psutka SP, Kim SP, Gross CP, Van Houten H, Thompson RH, Abouassaly R, Weight C, Boorjian SA, Leibovich BC, Shah ND. The impact of targeted therapy on management of metastatic renal cell carcinoma: trends in systemic therapy and cytoreductive nephrectomy utilization. Urology. 85: 442-50. PMID 25623717 DOI: 10.1016/j.urology.2014.10.040 |
0.387 |
|
| 2015 |
Miller AJ, Kurup AN, Schmit GD, Weisbrod AJ, Boorjian SA, Thompson RH, Lohse CM, Kor DJ, Callstrom MR, Atwell TD. Percutaneous Clinical T1a Renal Mass Ablation in the Octogenarian and Nonagenarian: Oncologic Outcomes and Morbidity. Journal of Endourology / Endourological Society. 29: 671-6. PMID 25386995 DOI: 10.1089/end.2014.0733 |
0.333 |
|
| 2015 |
Psutka SP, Boorjian SA, Lohse CM, Stewart SB, Tollefson MK, Cheville JC, Leibovich BC, Thompson RH. The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma. Urologic Oncology. 33: 67.e15-23. PMID 25153774 DOI: 10.1016/j.urolonc.2014.07.008 |
0.426 |
|
| 2015 |
Thompson RH, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, Psutka SP, Stewart SB, Callstrom MR, Cheville JC, Boorjian SA, Leibovich BC. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. European Urology. 67: 252-9. PMID 25108580 DOI: 10.1016/j.eururo.2014.07.021 |
0.309 |
|
| 2015 |
Zhang BY, Thompson RH, Lohse CM, Leibovich BC, Boorjian SA, Cheville JC, Costello BA. A novel prognostic model for patients with sarcomatoid renal cell carcinoma. Bju International. 115: 405-11. PMID 24730416 DOI: 10.1111/bju.12781 |
0.409 |
|
| 2015 |
Viers B, Boorjian S, Lohse C, Psutka S, Morrisson G, Leibovich B, Thompson RH. MP50-10 INCIDENCE AND RISK FACTORS FOR PERIOPERATIVE THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH RENAL CELL CARCINOMA AND INFERIOR VENA CAVA TUMOR THROMBUS Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.2921 |
0.398 |
|
| 2015 |
Psutka S, Thompson RH, Boorjian S, Lohse C, Stewart S, Cheville J, Leibovich B. MP70-15 INCREASING COMPLEXITY OF TUMOR THROMBI IN RENAL CELL CARCINOMA OVER 40 YEARS OF EXPERIENCE Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.2540 |
0.393 |
|
| 2015 |
Psutka S, Thompson RH, Boorjian S, Lohse C, Stewart S, Carrasco A, Cheville J, Leibovich B. MP70-14 THE ONCOLOGIC IMPACT OF POSITIVE VASCULAR WALL SURGICAL MARGINS IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS UNDERGOING NEPHRECTOMY Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.2539 |
0.419 |
|
| 2015 |
Psutka S, Thompson RH, Boorjian S, Cheville J, Stewart S, Lohse C, Costello B, Que F, Leibovich B. MP70-12 IS CONCOMITANT HEPATIC RESECTION FOR LOCALLY ADVANCED OR METASTATIC RENAL CELL CARCINOMA AT THE TIME OF NEPHRECTOMY SAFE? A MATCHED COHORT STUDY Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.2537 |
0.42 |
|
| 2015 |
Psutka S, Boorjian S, Thompson RH, Schmit G, Schmitz J, Bower T, Stewart S, Lohse C, Cheville J, Leibovich B. MP70-11 RADIOGRAPHIC PREDICTORS OF THE NEED FOR INFERIOR VENA CAVAL RESECTION DURING NEPHRECTOMY FOR PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.2536 |
0.46 |
|
| 2015 |
Viers B, Thompson RH, Psutka S, Lohse C, Leibovich B, Tollefson M, Boorjian S. MP69-12 THE ASSOCIATION OF STATIN THERAPY WITH CLINICOPATHOLOGIC OUTCOMES AND SURVIVAL AMONG PATIENTS WITH LOCALIZED RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.2516 |
0.403 |
|
| 2015 |
Rieken M, Boorjian S, Kluth L, Xylinas E, Capitanio U, Briganti A, Thompson RH, Leibovich B, Krabbe L, Margulis V, Raman J, Regelman M, Klatte T, Bachmann A, Karakiewicz P, et al. MP63-20 DEVELOPMENT AND EXTERNAL VALIDATION OF A PATHOLOGICAL NODAL STAGING SCORE FOR PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.2352 |
0.393 |
|
| 2015 |
Psutka S, Heidenreich M, Boorjian S, Bailey GC, Cheville J, Stewart S, Lohse C, Atwell T, Costello B, Leibovich B, Thompson RH. PD35-07 EVALUATION AND MANAGEMENT OF RENAL FOSSA RECURRENCE FOLLOWING NEPHRECTOMY FOR RENAL CELL CARCINOMA Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.2230 |
0.434 |
|
| 2015 |
Stewart S, Thompson RH, Boorjian S, Psutka S, Lohse C, Cheville J, Leibovich B, Frank I. PD29-06 ONCOLOGIC SURVEILLANCE FOLLOWING SURGICAL RESECTION FOR RENAL CELL CARCINOMA: A NOVEL RISK-BASED APPROACH Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.1793 |
0.36 |
|
| 2015 |
Psutka S, Moynagh M, Schmit G, Thompson RH, Boorjian S, Stewart S, Lohse C, Cheville J, Leibovich B, Tollefson M. MP35-19 THE IMPACT OF EXCESS FAT MASS ON MORTALITY AFTER RADICAL NEPHRECTOMY FOR RENAL CELL CARCINOMA: BEYOND BODY MASS INDEX Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.1120 |
0.309 |
|
| 2015 |
Psutka S, Moynagh M, Schmit G, Thompson RH, Boorjian S, Stewart S, Lohse C, Cheville J, Leibovich B, Tollefson M. MP35-18 SARCOPENIA IS INDEPENDENTLY ASSOCIATED WITH INCREASED MORTALITY FOLLOWING RADICAL NEPHRECTOMY FOR LOCALIZED RENAL CELL CARCINOMA Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.02.1119 |
0.406 |
|
| 2014 |
Psutka SP, Boorjian SA, Thompson RH, Schmit GD, Schmitz JJ, Bower TC, Stewart SB, Lohse CM, Cheville JC, Leibovich BC. Clinical and radiographic predictors of the need for inferior vena cava resection during nephrectomy for patients with renal cell carcinoma and caval tumour thrombus. Bju International. PMID 25430786 DOI: 10.1111/bju.13005 |
0.424 |
|
| 2014 |
Stewart SB, Thompson RH, Psutka SP, Cheville JC, Lohse CM, Boorjian SA, Leibovich BC. Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 4059-65. PMID 25403213 DOI: 10.1200/JCO.2014.56.5416 |
0.374 |
|
| 2014 |
Psutka SP, Stewart SB, Boorjian SA, Lohse CM, Tollefson MK, Cheville JC, Leibovich BC, Thompson RH. Diabetes mellitus is independently associated with an increased risk of mortality in patients with clear cell renal cell carcinoma. The Journal of Urology. 192: 1620-7. PMID 24931804 DOI: 10.1016/j.juro.2014.06.014 |
0.367 |
|
| 2014 |
Haddad AQ, Wood CG, Abel EJ, Krabbe LM, Darwish OM, Thompson RH, Heckman JE, Merril MM, Gayed BA, Sagalowsky AI, Boorjian SA, Margulis V, Leibovich BC. Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort. The Journal of Urology. 192: 1050-6. PMID 24704115 DOI: 10.1016/j.juro.2014.03.111 |
0.46 |
|
| 2014 |
Schmit GD, Kurup AN, Weisbrod AJ, Thompson RH, Boorjian SA, Wass CT, Callstrom MR, Atwell TD. ABLATE: a renal ablation planning algorithm. Ajr. American Journal of Roentgenology. 202: 894-903. PMID 24660722 DOI: 10.2214/AJR.13.11110 |
0.318 |
|
| 2014 |
Welch BT, Callstrom MR, Morris JM, Kurup AN, Schmit GD, Weisbrod AJ, Lohse CM, Kohli M, Costello BA, Olivier KR, Thompson RH, Boorjian SA, Atwell TD. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma. The Journal of Urology. 192: 357-63. PMID 24631107 DOI: 10.1016/J.Juro.2014.03.006 |
0.428 |
|
| 2014 |
Carrasco A, Thompson RH, Leibovich BC, Lohse CM, Cheville JC, Boorjian SA. The impact of histology on survival for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. Indian Journal of Urology : Iju : Journal of the Urological Society of India. 30: 38-42. PMID 24497680 DOI: 10.4103/0970-1591.124204 |
0.436 |
|
| 2014 |
Linder BJ, Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Gastineau DA, Boorjian SA. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC). Bju International. 114: 368-74. PMID 24471825 DOI: 10.1111/bju.12535 |
0.307 |
|
| 2014 |
Kaag M, Trost L, Thompson RH, Favaretto R, Elliott V, Shariat SF, Maschino A, Vertosick E, Raman JD, Dalbagni G. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma. Bju International. 114: 674-9. PMID 24314050 DOI: 10.1111/bju.12597 |
0.424 |
|
| 2014 |
Abel EJ, Thompson RH, Margulis V, Heckman JE, Merril MM, Darwish OM, Krabbe LM, Boorjian SA, Leibovich BC, Wood CG. Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience. European Urology. 66: 584-92. PMID 24262104 DOI: 10.1016/j.eururo.2013.10.029 |
0.378 |
|
| 2014 |
Eisenberg MS, Thompson RH, Frank I, Kim SP, Cotter KJ, Tollefson MK, Kaushik D, Thapa P, Tarrell R, Boorjian SA. Long-term renal function outcomes after radical cystectomy. The Journal of Urology. 191: 619-25. PMID 24036234 DOI: 10.1016/j.juro.2013.09.011 |
0.314 |
|
| 2014 |
Thompson RH. Partial versus radical nephrectomy: the debate regarding renal function ends while the survival controversy continues. European Urology. 65: 378-9; discussion 37. PMID 23921423 DOI: 10.1016/j.eururo.2013.07.036 |
0.317 |
|
| 2014 |
Psutka S, Kim S, Gross C, Houten HV, Thompson RH, Abouassaly R, Weight C, Leibovich B, Shah N. Mp6-06 Population-Level Trends In The Adoption Of Novel Targeted Agents For Systemic Therapy And Impact On Rates Of Cytoreductive Nephrectomy For Metastatic Renal Cell Carcinoma The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.240 |
0.324 |
|
| 2014 |
Viers B, Thompson RH, Boorjian S, Lohse C, Leibovich B, Tollefson M. MP59-04 PREOPERATIVE NEUTROPHIL LYMPHOCYTE RATIO IS AN INDEPENDENT PREDICTOR OF CANCER SPECIFIC SURVIVAL IN PATIENTS WITH NONMETASTATIC CLEAR CELL RENAL CARCINOMA UNDERGOING RADICAL NEPHRECTOMY Journal of Urology. 191. DOI: 10.1016/J.JURO.2014.02.1800 |
0.42 |
|
| 2014 |
Abel EJ, Thompson RH, Margulis V, Heckman JE, Merrill MM, Darwish OM, Krabbe L, Boorjian SA, Leibovich BC, Wood CG. MP57-10 RISK FACTORS FOR MAJOR COMPLICATIONS AND PERIOPERATIVE MORTALITY FOLLOWING SURGICAL RESECTION OF RENAL CELL CARCINOMA WITH UPPER LEVEL IVC THROMBUS: A CONTEMPORARY MULTI-CENTER EXPERIENCE Journal of Urology. 191. DOI: 10.1016/J.JURO.2014.02.1785 |
0.396 |
|
| 2014 |
Psutka S, Boorjian S, Lohse C, Stewart S, Tollefson M, Leibovich B, Thompson RH. MP54-19 THE EFFECT OF METFORMIN IN PATIENTS WITH SURGICALLY TREATED RENAL CELL CARCINOMA Journal of Urology. 191. DOI: 10.1016/J.JURO.2014.02.1608 |
0.469 |
|
| 2014 |
Psutka S, Lohse C, Stewart S, Tollefson M, Boorjian S, Cheville J, Leibovich B, Thompson RH. MP54-12 DIABETES MELLITUS IS ASSOCIATED WITH AN INCREASED RISK OF CANCER-SPECIFIC MORTALITY AMONG PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY Journal of Urology. 191. DOI: 10.1016/J.JURO.2014.02.1601 |
0.345 |
|
| 2014 |
Linder B, Thompson RH, Leibovich B, Cheville J, Lohse C, Gastineau D, Boorjian S. PD16-03 THE IMPACT OF PERIOPERATIVE BLOOD TRANSFUSION ON SURVIVAL FOLLOWING NEPHRECTOMY FOR NON METASTATIC RENAL CELL CARCINOMA Journal of Urology. 191. DOI: 10.1016/J.JURO.2014.02.1148 |
0.33 |
|
| 2013 |
Thiel DD, Jorns J, Lohse CM, Cheville JC, Thompson RH, Parker AS. Maximum tumor diameter is not an accurate predictor of renal cell carcinoma tumor volume. Scandinavian Journal of Urology. 47: 472-5. PMID 23883351 DOI: 10.3109/21681805.2013.814071 |
0.383 |
|
| 2013 |
Kaushik D, Linder BJ, Thompson RH, Eisenberg MS, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA. The impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: a matched cohort analysis. Urology. 82: 136-41. PMID 23642851 DOI: 10.1016/j.urology.2013.02.034 |
0.398 |
|
| 2013 |
Zhang BY, Thompson RH, Lohse CM, Dronca RS, Cheville JC, Kwon ED, Leibovich BC. Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up. Bju International. 111: 1046-53. PMID 23551810 DOI: 10.1111/bju.12075 |
0.399 |
|
| 2013 |
Wang JK, Tollefson MK, Kim SP, Boorjian SA, Leibovich BC, Lohse CM, Cheville JC, Thompson RH. Iatrogenic splenectomy during nephrectomy for renal tumors. International Journal of Urology : Official Journal of the Japanese Urological Association. 20: 896-902. PMID 23379901 DOI: 10.1111/iju.12065 |
0.346 |
|
| 2013 |
Eisenberg MS, Cheville JC, Thompson RH, Kaushik D, Lohse CM, Boorjian SA, Costello BA, Leibovich BC. Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma. The Journal of Urology. 190: 37-43. PMID 23353044 DOI: 10.1016/j.juro.2013.01.044 |
0.441 |
|
| 2013 |
Delahunt B, McKenney JK, Lohse CM, Leibovich BC, Thompson RH, Boorjian SA, Cheville JC. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis. The American Journal of Surgical Pathology. 37: 311-22. PMID 23348209 DOI: 10.1097/PAS.0b013e318270f71c |
0.347 |
|
| 2013 |
Atwell TD, Schmit GD, Boorjian SA, Mandrekar J, Kurup AN, Weisbrod AJ, Chow GK, Leibovich BC, Callstrom MR, Patterson DE, Lohse CM, Thompson RH. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. Ajr. American Journal of Roentgenology. 200: 461-6. PMID 23345372 DOI: 10.2214/AJR.12.8618 |
0.543 |
|
| 2013 |
Kim SP, Thompson RH. Kidney function after partial nephrectomy: current thinking. Current Opinion in Urology. 23: 105-11. PMID 23321635 DOI: 10.1097/MOU.0b013e32835d8ec1 |
0.32 |
|
| 2013 |
Kaushik D, Kim SP, Childs MA, Lohse CM, Costello BA, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. European Urology. 64: 600-6. PMID 23280319 DOI: 10.1016/j.eururo.2012.12.023 |
0.398 |
|
| 2013 |
Linder BJ, Frank I, Cheville JC, Thompson RH, Thapa P, Tarrell RF, Boorjian SA. Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis. The Journal of Urology. 189: 1670-5. PMID 23142686 DOI: 10.1016/j.juro.2012.11.006 |
0.33 |
|
| 2013 |
Hegg RM, Schmit GD, Boorjian SA, McDonald RJ, Kurup AN, Weisbrod AJ, Callstrom MR, Atwell TD, Thompson RH. Percutaneous renal cryoablation after partial nephrectomy: technical feasibility, complications and outcomes. The Journal of Urology. 189: 1243-8. PMID 23123377 DOI: 10.1016/j.juro.2012.10.066 |
0.429 |
|
| 2013 |
Junker K, Ficarra V, Kwon ED, Leibovich BC, Thompson RH, Oosterwijk E. Potential role of genetic markers in the management of kidney cancer. European Urology. 63: 333-40. PMID 23040205 DOI: 10.1016/j.eururo.2012.09.040 |
0.332 |
|
| 2013 |
Eisenberg MS, Cheville JC, Thompson RH, Kaushik D, Lohse C, Boorjian SA, Costello BA, Leibovich BC. 730 ASSOCIATION OF MICROVASCULAR AND CAPILLARY-LYMPHATIC INVASION WITH OUTCOME FOR PATIENTS WITH RENAL CELL CARCINOMA FOLLOWING NEPHRECTOMY Journal of Urology. 189. DOI: 10.1016/J.JURO.2013.02.293 |
0.445 |
|
| 2013 |
Kaushik D, Thompson RH, Eisenberg M, Lohse CM, Cheville JC, Leibovich BC, Boorjian SA. 1904 THE IMPACT OF NON-CLEAR CELL HISTOLOGY ON OUTCOME FOR PATIENT WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS Journal of Urology. 189. DOI: 10.1016/J.JURO.2013.02.2323 |
0.415 |
|
| 2012 |
Kim SP, Murad MH, Thompson RH, Boorjian SA, Weight CJ, Han LC, Erwin PJ, Costello BA, Chow GK, Leibovich BC. Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors: A Systematic Review and Meta-Analysis. The Journal of Urology. PMID 23085064 DOI: 10.1016/j.juro.2012.10.026 |
0.343 |
|
| 2012 |
Kim SP, Crispen PL, Thompson RH, Weight CJ, Boorjian SA, Costello BA, Lohse CM, Leibovich BC. Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma. Cancer. 118: 4412-20. PMID 22952032 DOI: 10.1002/cncr.26695 |
0.362 |
|
| 2012 |
Kim SP, Frank I, Cheville JC, Thompson RH, Weight CJ, Thapa P, Boorjian SA. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. The Journal of Urology. 188: 405-9. PMID 22704101 DOI: 10.1016/j.juro.2012.04.020 |
0.338 |
|
| 2012 |
Kim SP, Thompson RH, Boorjian SA, Weight CJ, Han LC, Murad MH, Shippee ND, Erwin PJ, Costello BA, Chow GK, Leibovich BC. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. The Journal of Urology. 188: 51-7. PMID 22591957 DOI: 10.1016/J.Juro.2012.03.006 |
0.315 |
|
| 2012 |
Schmit GD, Thompson RH, Kurup AN, Weisbrod AJ, Carter RE, Callstrom MR, Atwell TD. Percutaneous cryoablation of solitary sporadic renal cell carcinomas. Bju International. 110: E526-31. PMID 22584010 DOI: 10.1111/J.1464-410X.2012.11230.X |
0.408 |
|
| 2012 |
Sukov WR, Hodge JC, Lohse CM, Leibovich BC, Thompson RH, Pearce KE, Wiktor AE, Cheville JC. TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients. The American Journal of Surgical Pathology. 36: 663-70. PMID 22498819 DOI: 10.1097/Pas.0B013E31824Dd972 |
0.355 |
|
| 2012 |
Kim SP, Thompson RH. Approach to the small renal mass: to treat or not to treat. The Urologic Clinics of North America. 39: 171-9, vi. PMID 22487760 DOI: 10.1016/j.ucl.2012.01.003 |
0.303 |
|
| 2012 |
Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH. High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology. 79: 615-9. PMID 22386411 DOI: 10.1016/j.urology.2011.11.049 |
0.371 |
|
| 2012 |
Kim SP, Thompson RH. Challenges and changes for locally advanced upper tract urothelial carcinoma. European Urology. 62: 232-3. PMID 22336377 DOI: 10.1016/j.eururo.2012.01.056 |
0.303 |
|
| 2012 |
Sukov WR, Lohse CM, Leibovich BC, Thompson RH, Cheville JC. Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma. The Journal of Urology. 187: 54-9. PMID 22088335 DOI: 10.1016/j.juro.2011.09.053 |
0.416 |
|
| 2012 |
Atwell TD, Carter RE, Schmit GD, Carr CM, Boorjian SA, Curry TB, Thompson RH, Kurup AN, Weisbrod AJ, Chow GK, Leibovich BC, Callstrom MR, Patterson DE. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. Journal of Vascular and Interventional Radiology : Jvir. 23: 48-54. PMID 22037491 DOI: 10.1016/J.Jvir.2011.09.008 |
0.555 |
|
| 2012 |
Umbreit EC, Shimko MS, Childs MA, Lohse CM, Cheville JC, Leibovich BC, Blute ML, Thompson RH. Metastatic potential of a renal mass according to original tumour size at presentation Bju International. 109: 190-194. PMID 21557795 DOI: 10.1111/j.1464-410X.2011.10184.x |
0.307 |
|
| 2012 |
Kaag M, Trost L, Thompson RH, Favaretto R, Elliott V, Shariat S, Maschino A, Raman J, Dalbagni G. 639 PREOPERATIVE PREDICTORS OF RENAL FUNCTION DECLINE FOLLOWING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA Journal of Urology. 187. DOI: 10.1016/J.JURO.2012.02.718 |
0.438 |
|
| 2012 |
Kim S, Thompson RH, Weight C, Cheville J, Lohse C, Boorjian S, Leibovich B. 573 THE RELATIONSHIP OF LYMPH NODE DISSECTION WITH RECURRENCE AND SURVIVAL FOR PATIENTS TREATED WITH NEPHRECTOMY FOR HIGH-RISK RENAL CELL CARCINOMA Journal of Urology. 187. DOI: 10.1016/J.JURO.2012.02.649 |
0.365 |
|
| 2012 |
Kim S, Boorjian S, Thompson RH, Weight C, Wang J, Lohse C, Cheville J, Leibovich B. 1801 COMPLICATIONS AND OUTCOMES FOR PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS: RESULTS FROM THE MAYO CLINIC Journal of Urology. 187. DOI: 10.1016/J.JURO.2012.02.1832 |
0.421 |
|
| 2012 |
Kim S, Thompson RH, Boorjian S, Weight C, Shippee N, Chow G, Leibovich B. 1682 COMPARATIVE EFFECTIVENESS OF PARTIAL AND RADICAL NEPHRECTOMY FOR LOCALIZED RENAL TUMORS ON SURVIVAL AND RENAL FUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS Journal of Urology. 187. DOI: 10.1016/J.JURO.2012.02.1555 |
0.343 |
|
| 2011 |
Kim SP, Weight CJ, Leibovich BC, Thompson RH, Lohse CM, Boorjian SA. Predictors and outcomes for late recurrence of renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 348. PMID 27968702 DOI: 10.1200/jco.2011.29.7_suppl.348 |
0.433 |
|
| 2011 |
Weight CJ, Kim SP, Crispen PL, Breau RH, Boorjian SA, Thompson RH, Leibovich BC. Likelihood of high volume renal surgeons to offer elective partial nephrectomy in high complexity tumors as classified by the nephrometry scoring system. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 354. PMID 27968663 DOI: 10.1200/jco.2011.29.7_suppl.354 |
0.337 |
|
| 2011 |
Weight CJ, Kim SP, Thompson RH, Boorjian SA, Leibovich BC. Effect of routine ipsilateral adrenalectomy on cancer-specific survival and risk of adrenal insufficiency for patients with pT3/4 renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 324. PMID 27968631 DOI: 10.1200/jco.2011.29.7_suppl.324 |
0.395 |
|
| 2011 |
Kim SP, Shah ND, Weight CJ, Thompson RH, Moriarty JP, Shippee ND, Costello BA, Boorjian SA, Leibovich BC. Contemporary trends in nephrectomy for renal cell carcinoma in the united states: Results from a population based cohort Journal of Urology. 186: 1779-1785. PMID 21944105 DOI: 10.1016/J.Juro.2011.07.041 |
0.419 |
|
| 2011 |
Mitchell CR, Atwell TD, Weisbrod AJ, Lohse CM, Boorjian SA, Leibovich BC, Thompson RH. Renal function outcomes in patients treated with partial nephrectomy versus percutaneous ablation for renal tumors in a solitary kidney. The Journal of Urology. 186: 1786-90. PMID 21944103 DOI: 10.1016/j.juro.2011.07.036 |
0.402 |
|
| 2011 |
Kim SP, Weight CJ, Leibovich BC, Thompson RH, Costello BA, Cheville JC, Lohse CM, Boorjian SA. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma Urology. 78: 1101-1106. PMID 21903243 DOI: 10.1016/j.urology.2011.05.012 |
0.446 |
|
| 2011 |
Kim SP, Thompson RH. Competing-risks analysis for renal cell carcinoma: How do we accurately communicate the risks and benefits of treatment to patients? European Urology. 60: 1160-1162. PMID 21868148 DOI: 10.1016/j.eururo.2011.08.025 |
0.336 |
|
| 2011 |
Kim SP, Thompson RH. Sunitinib prior to planned cytoreductive nephrectomy: Is this the new litmus test for metastatic renal cell carcinoma? European Urology. 60: 455-456. PMID 21680083 DOI: 10.1016/j.eururo.2011.05.056 |
0.398 |
|
| 2011 |
Weight CJ, Kim SP, Lohse CM, Cheville JC, Thompson RH, Boorjian SA, Leibovich BC. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland European Urology. 60: 458-464. PMID 21514718 DOI: 10.1016/j.eururo.2011.04.022 |
0.432 |
|
| 2011 |
Frigola X, Inman BA, Lohse CM, Krco CJ, Cheville JC, Thompson RH, Leibovich B, Blute ML, Dong H, Kwon ED. Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1915-23. PMID 21355078 DOI: 10.1158/1078-0432.Ccr-10-0250 |
0.348 |
|
| 2011 |
Childs MA, Breau RH, Umbreit EC, Lohse CM, Cheville JC, Thompson RH, Blute ML, Leibovich BC. Metachronous renal tumours after surgical management of oncocytoma Bju International. 108: 816-819. PMID 21166765 DOI: 10.1111/j.1464-410X.2010.09946.x |
0.442 |
|
| 2011 |
Kim S, Weight C, Leibovich B, Thompson RH, Lohse C, Boorjian S. 1088 PREDICTORS AND OUTCOMES OF LATE RECURRENCE FROM RENAL CELL CARCINOMA FOLLOWING SURGICAL RESECTION Journal of Urology. 185. DOI: 10.1016/J.JURO.2011.02.1126 |
0.425 |
|
| 2011 |
Childs M, Lohse C, Cheville J, Boorjian S, Blute M, Leibovich B, Thompson RH. 1073 RADICAL NEPHRECTOMY FOR BENIGN RENAL MASSES IS ASSOCIATED WITH DIMINISHED OVERALL SURVIVAL COMPARED WITH PARTIAL NEPHRECTOMY Journal of Urology. 185. DOI: 10.1016/J.JURO.2011.02.1111 |
0.324 |
|
| 2010 |
Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC. Every minute counts when the renal hilum is clamped during partial nephrectomy. European Urology. 58: 340-5. PMID 20825756 DOI: 10.1016/j.eururo.2010.05.047 |
0.332 |
|
| 2010 |
Leibovich BC, Lohse CM, Crispen PL, Boorjian SA, Thompson RH, Blute ML, Cheville JC. Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma Journal of Urology. 183: 1309-1316. PMID 20171681 DOI: 10.1016/j.juro.2009.12.035 |
0.416 |
|
| 2010 |
Lowrance WT, Yee DS, Maschino AC, Cronin AM, Bernstein M, Thompson RH, Russo P. Developments in the surgical management of sporadic synchronous bilateral renal tumours Bju International. 105: 1093-1097. PMID 19751262 DOI: 10.1111/j.1464-410X.2009.08844.x |
0.379 |
|
| 2010 |
Lowrance WT, Thompson RH, Yee DS, Kaag M, Donat SM, Russo P. Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies Bju International. 105: 16-20. PMID 19583732 DOI: 10.1111/j.1464-410X.2009.08706.x |
0.303 |
|
| 2009 |
Thompson RH, Siddiqui S, Lohse CM, Leibovich BC, Russo P, Blute ML. Partial Versus Radical Nephrectomy for 4 to 7 cm Renal Cortical Tumors Journal of Urology. 182: 2601-2606. PMID 19836797 DOI: 10.1016/j.juro.2009.08.087 |
0.347 |
|
| 2009 |
Teloken PE, Thompson RH, Tickoo SK, Cronin A, Savage C, Reuter VE, Russo P. Prognostic Impact of Histological Subtype on Surgically Treated Localized Renal Cell Carcinoma Journal of Urology. 182: 2132-2136. PMID 19758615 DOI: 10.1016/j.juro.2009.07.019 |
0.468 |
|
| 2009 |
Thompson RH, Hill JR, Babayev Y, Cronin A, Kaag M, Kundu S, Bernstein M, Coleman J, Dalbagni G, Touijer K, Russo P. Metastatic renal cell carcinoma risk according to tumor size. The Journal of Urology. 182: 41-5. PMID 19450840 DOI: 10.1016/j.juro.2009.02.128 |
0.412 |
|
| 2009 |
Thompson RH, Kurta JM, Kaag M, Tickoo SK, Kundu S, Katz D, Nogueira L, Reuter VE, Russo P. Tumor Size is Associated With Malignant Potential in Renal Cell Carcinoma Cases Journal of Urology. 181: 2033-2036. PMID 19286217 DOI: 10.1016/j.juro.2009.01.027 |
0.328 |
|
| 2009 |
Kaag MG, Toyen C, Cronin AM, Thompson RH, Bernstein M, Russo P, Bains M. RETROSPECTIVE REVIEW OF THE MSKCC EXPERIENCE WITH RESECTION OF RENAL MASSES AND ASSOCIATED VENA CAVAL THROMBI Journal of Urology. 181: 495-495. DOI: 10.1016/S0022-5347(09)61400-2 |
0.329 |
|
| 2009 |
Teloken PE, Thompson RH, Tickoo SK, Cronin AM, Savage CJ, Reuter VE, Russo P. CLEAR CELL HISTOLOGY REPRESENTS WORSE PROGNOSIS IN PATIENTS UNDERGOING SURGICAL TREATMENT FOR RENAL CELL CARCINOMA Journal of Urology. 181: 355-356. DOI: 10.1016/S0022-5347(09)61008-9 |
0.459 |
|
| 2009 |
Thompson RH, Siddiqui S, Lohse CM, Leibovich BC, Russo P, Blute ML. SURVIVAL FOLLOWING PARTIAL VERSUS RADICAL NEPHRECTOMY FOR RENAL CORTICAL TUMORS 4-7CM Journal of Urology. 181: 320-321. DOI: 10.1016/S0022-5347(09)60912-5 |
0.302 |
|
| 2009 |
Leibovich BC, Lohse CM, Blute ML, Thompson RH, Kwon ED. IMMUNOHISTOCHEMICAL BIOMARKERS VERSUS CLINICAL AND PATHOLOGIC FEATURES IN THE PREDICTION OF SURVIVAL FOR PATIENTS WITH METASTATIC RENAL CELL Journal of Urology. 181: 249-250. DOI: 10.1016/S0022-5347(09)60711-4 |
0.302 |
|
| 2009 |
Thompson RH, Hill JR, Babayev Y, Cronin AM, Kaag M, Kundu SD, Bernstein M, Coleman JA, Dalbagni G, Touijer KA, Russo P. RISK OF METASTATIC RENAL CELL CARCINOMA ACCORDING TO TUMOR SIZE Journal of Urology. 181: 212-213. DOI: 10.1016/S0022-5347(09)60610-8 |
0.396 |
|
| 2008 |
Thompson RH, Ordonez MA, Iasonos A, Secin FP, Guillonneau B, Russo P, Touijer K. Renal Cell Carcinoma in Young and Old Patients-Is There a Difference? Journal of Urology. 180: 1262-1266. PMID 18707708 DOI: 10.1016/j.juro.2008.06.037 |
0.454 |
|
| 2008 |
Thompson RH, Zang X, Lohse CM, Leibovich BC, Slovin SF, Reuter VE, Cheville JC, Blute ML, Russo P, Kwon ED, Allison JP. Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. Cancer Research. 68: 6054-8. PMID 18676826 DOI: 10.1158/0008-5472.Can-08-0869 |
0.369 |
|
| 2008 |
Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract. Bju International. 102: 1107-10. PMID 18522631 DOI: 10.1111/j.1464-410X.2008.07766.x |
0.599 |
|
| 2008 |
Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW. Preoperative nomogram predicting 12-year probability of metastatic renal cancer. The Journal of Urology. 179: 2146-51; discussion . PMID 18423735 DOI: 10.1016/j.juro.2008.01.101 |
0.324 |
|
| 2008 |
Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. Urology. 71: 713-7. PMID 18267338 DOI: 10.1016/j.urology.2007.11.018 |
0.604 |
|
| 2008 |
Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, Blute ML. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. The Journal of Urology. 179: 468-71; discussion 4. PMID 18076931 DOI: 10.1016/J.JURO.2007.09.077 |
0.369 |
|
| 2008 |
Pettus JA, Jang TL, Thompson RH, Yossepowitch O, Kagiwada MA, Russo P. DECLININING BASELINE GFR IMPACTS SURVIVAL IN PATIENTS UNDERGOING PARTIAL OR RADICAL NEPHRECTOMY FOR RENAL CORTICAL TUMORS Journal of Urology. 179: 378-378. DOI: 10.1016/S0022-5347(08)61106-4 |
0.324 |
|
| 2008 |
Thompson RH, Raj GV, Leibovich BC, Russo P, Blute ML, Kattan MW. Preoperative Nomogram To Predict Positive Lymph Nodes During Nephrectomy For Renal Cell Carcinoma The Journal of Urology. 179: 212-212. DOI: 10.1016/S0022-5347(08)60611-4 |
0.334 |
|
| 2008 |
Crispen PL, Magera JS, Boorjian SA, Thompson RH, Lohse CM, Blute ML, Leibovich BC, Kwon ED. IDENTIFICATION OF POTENTIAL SERUM MARKERS IN CLEAR CELL RENAL CELL CARCINOMA Journal of Urology. 179: 166-167. DOI: 10.1016/S0022-5347(08)60482-6 |
0.402 |
|
| 2008 |
Roth TJ, Hoffmann NE, Thompson RH, Lohse CM, Kuntz SM, Leibovich BC, Blute ML, Sheinin Y, Kwon ED. COINHIBITORY MOLECULE EXPRESSION AND LYMPHOCYTIC INFILTRATION IN NON-CLEAR CELL RENAL CELL CARCINOMA Journal of Urology. 179: 134-135. DOI: 10.1016/S0022-5347(08)60386-9 |
0.37 |
|
| 2007 |
Webster WS, Thompson RH, Cheville JC, Lohse CM, Blute ML, Leibovich BC. Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma. Urology. 70: 900-4; discussion 90. PMID 18068445 DOI: 10.1016/j.urology.2007.05.029 |
0.427 |
|
| 2007 |
Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 4757-64. PMID 17947723 DOI: 10.1200/JCO.2007.12.1087 |
0.38 |
|
| 2007 |
Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Elliott DS, Blute ML. Imperative indications for conservative management of upper tract transitional cell carcinoma. The Journal of Urology. 178: 792-6; discussion 79. PMID 17632132 DOI: 10.1016/j.juro.2007.05.056 |
0.586 |
|
| 2007 |
Tollefson MK, Thompson RH, Sheinin Y, Lohse CM, Cheville JC, Leibovich BC, Kwon ED. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. Cancer. 110: 783-90. PMID 17594714 DOI: 10.1002/cncr.22840 |
0.404 |
|
| 2007 |
Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Segura JW, Zincke H, Elliott DS, Blute ML. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma. The Journal of Urology. 177: 1721-6. PMID 17437796 DOI: 10.1016/j.juro.2007.01.006 |
0.61 |
|
| 2007 |
Krambeck AE, Dong H, Thompson RH, Kuntz SM, Lohse CM, Leibovich BC, Blute ML, Sebo TJ, Cheville JC, Parker AS, Kwon ED. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 1749-56. PMID 17363528 DOI: 10.1158/1078-0432.CCR-06-2129 |
0.323 |
|
| 2007 |
Thompson RH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML, Frank I. Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score. The Journal of Urology. 177: 477-80. PMID 17222614 DOI: 10.1016/J.JURO.2006.09.057 |
0.347 |
|
| 2007 |
Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW. 1250: Pre-Surgical Nomogram Predicting 12-Year Probability of Metastatic Recurrence Following Nephrectomy for Renal Masses The Journal of Urology. 177: 412-412. DOI: 10.1016/S0022-5347(18)31464-2 |
0.344 |
|
| 2007 |
Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Blute ML. 641: Is Partial Nephrectomy for Small Renal Masses Associated with Improved Overall Survival Compared with Radical Nephrectomy? Journal of Urology. 177: 215-215. DOI: 10.1016/S0022-5347(18)30881-4 |
0.31 |
|
| 2007 |
Thompson RH, Blute ML, Krambeck AE, Lohse CM, Magera JS, Leibovich BC, Kwon ED, Frank I, Cheville JC. 507: Patients with PT1 Renal Cell Carcinoma who Die from Disease after Nephrectomy may have Unrecognized Renal Sinus Fat Invasion Journal of Urology. 177: 169-169. DOI: 10.1016/S0022-5347(18)30747-X |
0.434 |
|
| 2007 |
Krambeck AE, Dong H, Thompson RH, Kuntz SM, Lohse CM, Leibovich BC, Blute ML, Sebo TJ, Cheville JC, Parker AS, Kwon ED. 319: Survivin and B7-H1 are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal cell Carcinoma Journal of Urology. 177: 107-108. DOI: 10.1016/S0022-5347(18)30584-6 |
0.363 |
|
| 2006 |
Thompson RH. Radical nephrectomy: too radical for small renal masses? Lancet. 368: 823-824. PMID 16950341 DOI: 10.1016/S0140-6736(06)69302-1 |
0.307 |
|
| 2006 |
Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, Zincke H, Blute ML. Second primary malignancies associated with renal cell carcinoma histological subtypes. The Journal of Urology. 176: 900-3; discussion 90. PMID 16890648 DOI: 10.1016/j.juro.2006.04.080 |
0.462 |
|
| 2006 |
Webster WS, Lohse CM, Thompson RH, Dong H, Frigola X, Dicks DL, Sengupta S, Frank I, Leibovich BC, Blute ML, Cheville JC, Kwon ED. Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival. Cancer. 107: 46-53. PMID 16708355 DOI: 10.1002/Cncr.21951 |
0.349 |
|
| 2006 |
Sengupta S, Lohse CM, Cheville JC, Leibovich BC, Thompson RH, Webster WS, Frank I, Zincke H, Blute ML, Kwon ED. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma. Cancer. 106: 304-12. PMID 16353202 DOI: 10.1002/cncr.21617 |
0.428 |
|
| 2006 |
Webster WS, Cheville JC, Thompson RH, Lohse CM, Blute ML, Leibovich BC. 1110: Cystic Clear Cell Renal Cell Carcinoma is Cured by Surgical Resection Journal of Urology. 175: 357-357. DOI: 10.1016/S0022-5347(18)33335-4 |
0.445 |
|
| 2006 |
Krambeck AE, Thompson RH, Segura JW, Patterson DE, Zincke H, Blute ML, Elliott DS. 1100: Endoscopic Management of Upper Tract Urothelial Carcinoma in Patient with a History of Primary Bladder Urothelial Carcinoma Journal of Urology. 175: 354-354. DOI: 10.1016/S0022-5347(18)33325-1 |
0.419 |
|
| 2006 |
Webster WS, Lohse CM, Thompson RH, Dong H, Frigola X, Dicks D, Sengupta S, Frank I, Leibovich BC, Blute ML, Cheville JC, Kwon ED. 746: Mononuclear Cell Infiltration in Clear Cell Renal Cell Carcinoma Independently Predicts Patient Survival The Journal of Urology. 175: 242-243. DOI: 10.1016/S0022-5347(18)32982-3 |
0.387 |
|
| 2006 |
Webster WS, Dong H, Thompson RH, Sengupta S, Lohse CM, Leibovich BC, Blute ML, Kwon ED. 399: Complete Tumor Regression of Established Murine Renal Cell Carcinoma Following CD4+ T Cell Depletion and B7-H1 Blockade The Journal of Urology. 175: 130-130. DOI: 10.1016/S0022-5347(18)32655-7 |
0.315 |
|
| 2006 |
Thompson RH, Leibovich BC, Dong H, Lohse CM, Webster WS, Zincke H, Blute ML, Sebo TJ, Cheville JC, Kwon ED. 386: Tumor B7-H1 is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long Term Follow-Up The Journal of Urology. 175: 126-126. DOI: 10.1016/S0022-5347(18)32642-9 |
0.363 |
|
| 2006 |
Thompson RH, Dong H, Lohse CM, Cheville JC, Kwon ED. 385: PD-1 Expression by Tumor Infiltrating Lymphocytes is Associated with Poor Prognosis in Renal Cell Carcinoma Patients The Journal of Urology. 175: 126-126. DOI: 10.1016/S0022-5347(18)32641-7 |
0.348 |
|
| 2006 |
Thompson RH, Lohse CM, Frank I, Zincke H, Blute ML, Leibovich BC. 73: Preoperative and Intraoperative Features Associated with Positive Lymph Nodes During Nephrectomy for Renal Cell Carcinoma Journal of Urology. 175: 24-25. DOI: 10.1016/S0022-5347(18)32340-1 |
0.34 |
|
| 2006 |
Thompson RH, Krambeck AE, Patterson DE, Segura JW, Blute ML, Elliott DS. 47: Endoscopic Treatment of Upper Tract Urothelial Carcinoma in Patients with Solitary Kidneys Journal of Urology. 175: 16-17. DOI: 10.1016/s0022-5347(18)32314-0 |
0.432 |
|
| 2005 |
Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, Frank I, Zincke H, Blute ML. Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? The Journal of Urology. 174: 1218-21. PMID 16145373 DOI: 10.1097/01.JU.0000173942.19990.40 |
0.441 |
|
| 2005 |
Thompson RH, Leibovich BC, Lohse CM, Zincke H, Blute ML. Complications of contemporary open nephron sparing surgery: a single institution experience. The Journal of Urology. 174: 855-8. PMID 16093969 DOI: 10.1097/01.JU.0000169453.29706.42 |
0.304 |
|
| 2005 |
Sengupta S, Lohse CM, Leibovich BC, Frank I, Thompson RH, Webster WS, Zincke H, Blute ML, Cheville JC, Kwon ED. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer. 104: 511-20. PMID 15973740 DOI: 10.1002/cncr.21206 |
0.33 |
|
| 2005 |
Thompson RH, Cheville JC, Lohse CM, Webster WS, Zincke H, Kwon ED, Frank I, Blute ML, Leibovich BC. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Cancer. 104: 53-60. PMID 15895375 DOI: 10.1002/cncr.21125 |
0.4 |
|
| 2005 |
Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Frank I, Kwon ED, Zincke H, Blute ML. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? The Journal of Urology. 173: 918-21. PMID 15711327 DOI: 10.1097/01.JU.0000153419.98715.24 |
0.385 |
|
| 2005 |
Leibovich BC, Cheville JC, Lohse CM, Zincke H, Kwon ED, Frank I, Thompson RH, Blute ML. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved? The Journal of Urology. 173: 716-9. PMID 15711250 DOI: 10.1097/01.JU.0000151830.27750.D2 |
0.38 |
|
| 2005 |
Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Krejci KG, Lobo JR, Sengupta S, Chen L, Zincke H, Blute ML, Strome SE, Leibovich BC, Kwon ED. 618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target The Journal of Urology. 173: 169-169. DOI: 10.1016/S0022-5347(18)34858-4 |
0.366 |
|
| 2004 |
Thompson RH, Hartman RP, Lowe VJ, Kawashima A, Leibovich BC. Applications of positron emission tomography imaging, intraoperative ultrasonography, magnetic resonance imaging, and angiography in the evaluation of renal masses. Current Urology Reports. 5: 30-4. PMID 14733834 DOI: 10.1007/S11934-004-0008-8 |
0.318 |
|
| Show low-probability matches. |